Ameliorative effects of Alpinia calcarata in alloxan-induced diabetic rats

Digest Journal of Nanomaterials and Biostructures

Volumn 6, Issue 3, 2011, Pages 991-997

  Raj, Navin ^a   Nadeem, Sayyed ^a   Jain, Samir ^a   Raj, Chanchal ^a   Nandi, Kuldeep Chouhan Prithwish ^a  

^a Technocrats Institute of Technology Pharmacy   (India)

Author keywords

Alloxan; Diabetes mellitus; Ethanolic extract; Rhizomes of Alpinia calcarata

Indexed keywords

ALPINIA; ALPINIA CALCARATA; RATTUS; ZINGIBERACEAE;

EID: 79959640933     PISSN: None     EISSN: 18423582     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. V. S. Patel, V. Chitra, P. L. Prasanna, V. Krishnaraju, Indian J Pharmacol 40, 183 (2008).
2. W. Asulander, D. Haire-Joshu, C. Houston, C.W. Rhee, J.H. Williams, Diabetes Care 25, 809 (2002).
3. S.D. Anturlikar, S. Gopumadavan, B.L. Chauhan, S.K. Mitra, Indian J Physiol Pharmacol 39, 95 (1995).
4. C.R. Khan, S. Y. Goodman and Gilman, the Pharmacological basis of Therapeutics. 8th ed. New York, Pergameo Press 93 (1991).
5. M.J. Fowler, Clin Diabetes 25, 131(2007).
6. S.S. Handa, Herbal raw materials and traditional remedies. Eastern Pharmacist 38, 23 (1995).
7. K.N. Bopanna, S.P. Rathod, Indian J Pharmacol 29, 162(1997).
8. M.D. Dassanayake, F.R. Fosberg, A Revised Hand Book to the Flora of Ceylon, Amreind, New Delhi (1981).
9. D.M.A. Jayaweera, Medicinal Plants Used in Ceylon, vol. V, National Science Council of Sri Lanka. (p. 213). Colombo (1982).
10. L.Y. Kong, M.J. Qin, M. Niwa, J. Nat. Prod 63, 939 (2000).
11. L.Y. Kong, M.J. Qin, M. Niwa, Planta Med 68, 813 (2002).
12. P.S. Merh, M. Daniel, S.D. Sabnis, Curr. Sci 55, 835 (1986).
13. M. George, K.M. Pandalai, Indian J Med Res 37, 169 (1949).
14. P. Pushpangadan, C.K. Atal, J Ethol 111, 59 (1984).
15. R.R. Kaleysa, Indian J Physiol Pharmacol 19, 47 (1975).
16. TheWealth of India Raw Materials. A Dictionary of Indian Raw Materials and Industrial Products, vol. I A. National Institute of Science Communication and Information Resources, CSIR (p. 198), New Delhi (2003).
17. N.R. Farnsworth, J. Pharm. Sci 55, 225 (1996).
18. N Jothivel, S.P. Ponnusamy, M. Appachi, S. Singaravel, D. Rasilingam, K. Deivasigamani, S. Thangavel, J. Health Sci 53, 663 (2007).
19. K. Rajagopal, K. Sasikala, Singapore Med J 49, 137 (2008).
20. F.I. Milagro, J.A. Martínez, J Pharm Pharmacol 52, 851(2000).
21. A. Latner, Clinical Biochemistry, Philadelphia (p. 48-50). Saunders (1958).
22. L.B. Pupim, O. Heimbürger, A.R. Qureshi, T.A. Ikizler, P. Stenvinkel, Kidney Int 68, 2368 (2005).
23. N. Kamalakkannan, P.S. Prince, Basic Clin Pharmacol Toxicol 98, 97 (2006).
24. Z.S. Hakim, B.K. Patel, R.K. Goyal, Indian J Physiol Pharmacol 41, 353 (1997).
25. A. Shirwaikar, K. Rajendran, C. D. Kumar, R. Bodla, J Ethol 91, 171 (2004).
26. A. Shirwaikar, K. Rajendran, R. Barik, J Ethol 107, 285 (2006).
27. L. al-Shamaony, S.M. al-Khazraji, H.A. Twaij, J Ethol 43,167 (1994).
28. K.N. Bopanna, J. Kannan, G. Sushma, R. Balaraman, Rathod, Indian J Pharmacol 29,162 (1997).
29. J. Shepherd, Atherosclerosis supp 6, 15 (2005).
30. A. Shirwaikar, K. Rajendran, I.S.R. Punitha, J Ethol 97, 369 (2005).